These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 26148225

  • 21. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S, Zhang J, Mei TT, Guo HQ, Wei XH, Zhang WY, Liu YL, Liang S, Fan ZP, Ma LX, Lin W, Liu YR, Qiu LX, Yu HB.
    BMC Med Genet; 2020 Aug 18; 21(1):163. PubMed ID: 32811452
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients.
    Liu ZT, Chen TC, Lu XX, Cheng J, Xie HY, Zhou L, Zheng SS.
    World J Gastroenterol; 2015 Sep 14; 21(34):10054-6. PubMed ID: 26379412
    [Abstract] [Full Text] [Related]

  • 24. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML.
    Surg Obes Relat Dis; 2015 Sep 14; 11(4):888-94. PubMed ID: 25240529
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.
    Hepatology; 2010 Apr 14; 51(4):1209-17. PubMed ID: 20373368
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
    Liu YL, Patman GL, Leathart JB, Piguet AC, Burt AD, Dufour JF, Day CP, Daly AK, Reeves HL, Anstee QM.
    J Hepatol; 2014 Jul 14; 61(1):75-81. PubMed ID: 24607626
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S, Pirola CJ.
    Hepatology; 2011 Jun 14; 53(6):1883-94. PubMed ID: 21381068
    [Abstract] [Full Text] [Related]

  • 34. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M, Rau M, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Lammert F, Geier A, NAFLD Clinical Study Group.
    J Lipid Res; 2017 Jan 14; 58(1):247-255. PubMed ID: 27836992
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans.
    Lallukka S, Luukkonen PK, Zhou Y, Isokuortti E, Leivonen M, Juuti A, Hakkarainen A, Orho-Melander M, Lundbom N, Olkkonen VM, Lassila R, Yki-Järvinen H.
    Thromb Haemost; 2017 Jan 26; 117(2):286-294. PubMed ID: 27929200
    [Abstract] [Full Text] [Related]

  • 37. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
    Martínez LA, Larrieta E, Kershenobich D, Torre A.
    Ann Hepatol; 2017 Jan 26; 16(6):909-915. PubMed ID: 29055919
    [Abstract] [Full Text] [Related]

  • 38. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States.
    Wijarnpreecha K, Scribani M, Raymond P, Harnois DM, Keaveny AP, Ahmed A, Kim D.
    J Gastroenterol Hepatol; 2020 Oct 26; 35(10):1789-1794. PubMed ID: 32220085
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study.
    Kuttner CS, Mancina R, Wagenpfeil G, Lammert F, Stokes CS.
    Lifestyle Genom; 2019 Oct 26; 12(1-6):10-17. PubMed ID: 31454802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.